Feb 3, 2022 Intellia Therapeutics has entered into an agreement to acquire Rewrite Therapeutics .

Intellia Therapeutics based at Cambridge, Massachusetts, United States.
” Health Care, Therapeutics”

Acquirer’s Website: http://www.intelliatx.com

Rewrite Therapeutics based at Berkeley, California, United States. “Rewriting the treatment of genetic disease. Safely make any edit anywhere with the first gene editor that is deliverable with AAV and LNP, and can precisely and accurately edit genomes in dividing and non-dividing cells.”

Acquiree’s Website: http://www.rewritetherapeutics.com